ストックスクリーナーアプリを入手
1.04
2.97%
0.03
アフターアワーズ：
1.03
-0.01
-0.96%
前日終値:
$1.01
開ける：
$1.03
24時間の取引高:
162.02K
Relative Volume:
0.31
時価総額：
$24.60M
収益：
-
当期純損益:
$-14.33M
株価収益率:
-1.5758
EPS:
-0.66
ネットキャッシュフロー:
$-13.21M
1週間 パフォーマンス:
-0.95%
1か月 パフォーマンス:
-0.95%
6か月 パフォーマンス:
+7.19%
1年 パフォーマンス:
-38.10%
1日の値動き範囲:
$1.02
$1.04
1週間の範囲:
$1.01
$1.06
52週間の値動き範囲:
$0.8101
$2.10
Enlivex Therapeutics Ltd Stock (ENLV) Company Profile
ENLV を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
ENLV
Enlivex Therapeutics Ltd
|
1.04 | 24.54M | 0 | -14.33M | -13.21M | -0.66 |
|
VRTX
Vertex Pharmaceuticals Inc
|
391.64 | 101.35B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
456.00 | 58.66B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
562.27 | 59.43B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
737.56 | 44.01B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
340.70 | 36.56B | 3.81B | -644.79M | -669.77M | -6.24 |
Enlivex Therapeutics Ltd Stock (ENLV) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2021-03-02 | 繰り返されました | H.C. Wainwright | Buy |
Enlivex Therapeutics Ltd (ENLV) 最新ニュース
Building trade automation scripts for Enlivex Therapeutics Ltd.Weekly Trade Analysis & Reliable Entry Point Alerts - newser.com
What analysts say about Enlivex Therapeutics Ltd stockFundamental Stock Analysis & Fast Profit Trading Ideas - earlytimes.in
Sector ETF performance correlation with Enlivex Therapeutics Ltd.Portfolio Performance Report & High Accuracy Buy Signal Tips - newser.com
Will Enlivex Therapeutics Ltd. stock maintain momentum in 2025Quarterly Growth Report & Technical Buy Zone Confirmations - newser.com
How Enlivex Therapeutics Ltd. stock performs in weak economyJuly 2025 PostEarnings & Safe Capital Investment Plans - newser.com
Candlestick signals on Enlivex Therapeutics Ltd. stock today2025 Market Overview & Trade Opportunity Analysis Reports - newser.com
Is Enlivex Therapeutics Ltd. stock reversal real or fakeWeekly Gains Summary & Long Hold Capital Preservation Plans - newser.com
Can volume confirm reversal in Enlivex Therapeutics Ltd.Analyst Upgrade & Accurate Intraday Trade Tips - newser.com
Visual trend scoring systems applied to Enlivex Therapeutics Ltd.2025 Risk Factors & Fast Gain Stock Tips - newser.com
What Fibonacci levels say about Enlivex Therapeutics Ltd. reboundTrade Risk Summary & Fast Exit and Entry Strategy Plans - newser.com
How rising interest rates impact Enlivex Therapeutics Ltd. stockJuly 2025 Earnings & Reliable Trade Execution Plans - newser.com
Enlivex Therapeutics to Join Live Investor Webinar on Knee Osteoarthritis Treatment Advances - Quiver Quantitative
D. Boral Capital to Host KOL Webinar With World Leading Experts Featuring Insights & Breakthroughs from Enlivex's Knee Osteoarthritis Program - Yahoo Finance
Enlivex Therapeutics (NASDAQ:ENLV) Receives “Buy” Rating from D. Boral Capital - Defense World
Enlivex Therapeutics Announces Annual General Meeting for November 2025 - The Globe and Mail
Is Enlivex Therapeutics Ltd a good long term investmentStock Rotation Strategies & Build Capital Safely - Early Times
ENLV: D. Boral Capital Maintains Buy Rating with $13 Price Targe - GuruFocus
D. Boral Capital Maintains Enlivex Therapeutics (ENLV) Buy Recommendation - Nasdaq
Enlivex Therapeutics schedules annual general meeting for November 10 By Investing.com - Investing.com Nigeria
Enlivex Therapeutics schedules annual general meeting for November 10 - Investing.com
Enlivex Therapeutics Ltd (ENLV) 財務データ
収益
当期純利益
現金流量
EPS
2.36%
1.10%
大文字化:
|
ボリューム (24 時間):